BBLG Q3 2019 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q3 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$301,000

Net Income

-$561,000

EPS (Diluted)

$-10.98

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$474,538

Free Cash Flow

-$474,538

Stock-Based Comp.

$7,294

Balance Sheet

Total Assets

$249,345

Total Liabilities

$12M

Stockholders' Equity

-$11M

Cash & Equivalents

$201,834

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$301,000	$404,791	-174.4%
Net Income	-$561,000	-$242,000	-131.8%